Your browser doesn't support javascript.
loading
A combination of low-dose systemic etretinate and topical calcipotriol/betamethasone dipropionate treatment for hyperkeratosis and itching in Olmsted syndrome associated with a TRPV3 mutation.
Takeichi, Takuya; Tsukamoto, Katsuhiko; Okuno, Yusuke; Kojima, Daiei; Kono, Michihiro; Suga, Yasushi; Akiyama, Masashi.
Afiliação
  • Takeichi T; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: takeichi@med.nagoya-u.ac.jp.
  • Tsukamoto K; Department of Dermatology, Yamanashi Prefectural Central Hospital, Kofu, Japan.
  • Okuno Y; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kojima D; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kono M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Suga Y; Department of Dermatology, Juntendo University Urayasu Hospital, Urayasu, Japan.
  • Akiyama M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: makiyama@med.nagoya-u.ac.jp.
J Dermatol Sci ; 88(1): 144-146, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28587736
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Calcitriol / Betametasona / Etretinato / Ceratolíticos / Ceratose Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Calcitriol / Betametasona / Etretinato / Ceratolíticos / Ceratose Idioma: En Ano de publicação: 2017 Tipo de documento: Article